Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.41 - $2.91 $29,677 - $61,249
-21,048 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.74 - $4.82 $8,376 - $14,734
-3,057 Reduced 12.68%
21,048 $58,000
Q4 2021

Feb 15, 2022

BUY
$4.19 - $13.97 $3,666 - $12,223
875 Added 3.77%
24,105 $118,000
Q3 2021

Nov 15, 2021

BUY
$11.15 - $18.6 $81,060 - $135,222
7,270 Added 45.55%
23,230 $294,000
Q2 2021

Aug 16, 2021

SELL
$15.4 - $31.46 $48,848 - $99,791
-3,172 Reduced 16.58%
15,960 $247,000
Q1 2021

May 18, 2021

BUY
$25.86 - $39.93 $494,753 - $763,940
19,132 New
19,132 $630,000

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $21.8M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.